Gonadotropin-Releasing Hormone
"Gonadotropin-Releasing Hormone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND.
| Descriptor ID |
D007987
|
| MeSH Number(s) |
D06.472.699.327.740.320 D12.644.400.400.740.320 D12.644.456.460 D12.644.548.365.740.320 D12.776.631.650.405.740.320
|
| Concept/Terms |
Gonadotropin-Releasing Hormone- Gonadotropin-Releasing Hormone
- Gonadotropin Releasing Hormone
- Gn-RH
- Gonadoliberin
- LHFSH Releasing Hormone
- Releasing Hormone, LHFSH
- LH-RH
- LFRH
- LH-Releasing Hormone
- LH Releasing Hormone
- LH-FSH Releasing Hormone
- LH FSH Releasing Hormone
- LHFSHRH
- LHRH
- Luliberin
- Gonadorelin
- Luteinizing Hormone-Releasing Hormone
- Luteinizing Hormone Releasing Hormone
- FSH-Releasing Hormone
- FSH Releasing Hormone
- GnRH
|
Below are MeSH descriptors whose meaning is more general than "Gonadotropin-Releasing Hormone".
Below are MeSH descriptors whose meaning is more specific than "Gonadotropin-Releasing Hormone".
This graph shows the total number of publications written about "Gonadotropin-Releasing Hormone" by people in this website by year, and whether "Gonadotropin-Releasing Hormone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 5 | 8 |
| 2018 | 8 | 7 | 15 |
| 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Gonadotropin-Releasing Hormone" by people in Profiles.
-
Willingness of Women with Endometriosis Planning to Undergo IVF to Participate in a Randomized Clinical Trial and the Effects of the COVID-19 Pandemic on Potential Participation. Reprod Sci. 2022 02; 29(2):620-626.
-
Cardiovascular Toxicities of Androgen Deprivation Therapy. Curr Treat Options Oncol. 2021 04 17; 22(6):47.
-
Potential roles for the kisspeptin/kisspeptin receptor system in implantation and placentation. Hum Reprod Update. 2019 05 01; 25(3):326-343.
-
Gonadotropin releasing hormone antagonist use in controlled ovarian stimulation and intrauterine insemination cycles in women with polycystic ovary syndrome. Taiwan J Obstet Gynecol. 2019 Mar; 58(2):234-238.
-
Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application. Cancer Treat Rev. 2019 Jan; 72:65-77.
-
Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate Cancer. Eur Urol. 2019 04; 75(4):676-683.
-
Occupational manganese exposure, reproductive hormones, and semen quality in male workers: A cross-sectional study. Toxicol Ind Health. 2019 Jan; 35(1):53-62.
-
Reply to V. Turan et al. J Clin Oncol. 2019 01 01; 37(1):86-88.
-
Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study. Acta Oncol. 2019 Jan; 58(1):110-118.
-
Phase 2 Randomized Study of Radiation Therapy and 3-Year Androgen Deprivation With or Without Concurrent Weekly Docetaxel in High-Risk Localized Prostate Cancer Patients. Int J Radiat Oncol Biol Phys. 2019 02 01; 103(2):344-352.